These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15309702)

  • 1. The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy.
    Havranek EP; Simon TA; L'Italien G; Smitten A; Hauber AB; Chen R; Lapuerta P
    J Card Fail; 2004 Aug; 10(4):339-43. PubMed ID: 15309702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failure.
    Havranek EP; McGovern KM; Weinberger J; Brocato A; Lowes BD; Abraham WT
    J Card Fail; 1999 Jun; 5(2):85-91. PubMed ID: 10404347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A health perception score predicts cardiac events in patients with heart failure: results from the IMPRESS trial.
    Havranek EP; Lapuerta P; Simon TA; L'Italien G; Block AJ; Rouleau JL
    J Card Fail; 2001 Jun; 7(2):153-7. PubMed ID: 11420767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Ambrosy AP; Cerbin LP; DeVore AD; Greene SJ; Kraus WE; O'Connor CM; Piña IL; Whellan DJ; Wojdyla D; Wu A; Mentz RJ
    Am Heart J; 2017 Apr; 186():130-138. PubMed ID: 28454828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial.
    Cichosz SL; Ehlers LH; Hejlesen O
    Trials; 2016 Dec; 17(1):590. PubMed ID: 27955682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
    Solomon SD; Skali H; Bourgoun M; Fang J; Ghali JK; Martelet M; Wojciechowski D; Ansmite B; Skards J; Laks T; Henry D; Packer M; Pfeffer MA;
    Am Heart J; 2005 Aug; 150(2):257-62. PubMed ID: 16086927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences of heart failure patients in daily clinical practice: quality of life or longevity?
    Kraai IH; Vermeulen KM; Luttik ML; Hoekstra T; Jaarsma T; Hillege HL
    Eur J Heart Fail; 2013 Oct; 15(10):1113-21. PubMed ID: 23650130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilities derived from visual analog scale scores in patients with HIV/AIDS.
    Mrus JM; Yi MS; Freedberg KA; Wu AW; Zackin R; Gorski H; Tsevat J
    Med Decis Making; 2003; 23(5):414-21. PubMed ID: 14570299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
    Packer M; Califf RM; Konstam MA; Krum H; McMurray JJ; Rouleau JL; Swedberg K
    Circulation; 2002 Aug; 106(8):920-6. PubMed ID: 12186794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
    Lewis EF; Li Y; Pfeffer MA; Solomon SD; Weinfurt KP; Velazquez EJ; Califf RM; Rouleau JL; Kober L; White HD; Schulman KA; Reed SD
    JACC Heart Fail; 2014 Apr; 2(2):159-65. PubMed ID: 24720924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry.
    Berg J; Lindgren P; Mejhert M; Edner M; Dahlström U; Kahan T
    Value Health; 2015 Jun; 18(4):439-48. PubMed ID: 26091598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers.
    Cosmi F; Di Giulio P; Masson S; Finzi A; Marfisi RM; Cosmi D; Scarano M; Tognoni G; Maggioni AP; Porcu M; Boni S; Cutrupi G; Tavazzi L; Latini R;
    Circ Heart Fail; 2015 May; 8(3):428-37. PubMed ID: 25925415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Utility of the Minnesota Living With Heart Failure Questionnaire for assessing quality of life in heart failure patients].
    Morcillo C; Aguado O; Delás J; Rosell F
    Rev Esp Cardiol; 2007 Oct; 60(10):1093-6. PubMed ID: 17953932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences for quality of life or survival expressed by patients with heart failure.
    Lewis EF; Johnson PA; Johnson W; Collins C; Griffin L; Stevenson LW
    J Heart Lung Transplant; 2001 Sep; 20(9):1016-24. PubMed ID: 11557198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation.
    Flint KM; Spertus JA; Tang F; Jones P; Fendler TJ; Allen LA
    BMC Cardiovasc Disord; 2017 Mar; 17(1):78. PubMed ID: 28288574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of impedance cardiography parameters with changes in functional and quality-of-life measures in patients with chronic heart failure.
    Vijayaraghavan K; Crum S; Cherukuri S; Barnett-Avery L
    Congest Heart Fail; 2004; 10(2 Suppl 2):22-7. PubMed ID: 15073482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.